GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » C-Rad AB (OSTO:CRAD B) » Definitions » Short Interest

C-Rad AB (OSTO:CRAD B) Short Interest


View and export this data going back to 2007. Start your Free Trial

What is C-Rad AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of C-Rad AB's Short Interest

For the Medical Devices subindustry, C-Rad AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

C-Rad AB's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, C-Rad AB's Short Interest distribution charts can be found below:

* The bar in red indicates where C-Rad AB's Short Interest falls into.


;
;

C-Rad AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » C-Rad AB (OSTO:CRAD B) » Definitions » Short Interest
Comparable Companies
OSTO:BACTI B OSTO:SEDANA OSTO:OSSD OSTO:PAX OSTO:SEZI OSTO:INTEG B OSTO:BRAIN OSTO:MNTC OSTO:PRO OSTO:BOUL ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
0R44:UK 24C:Germany
Address
Sjukhusvagen 12K, Uppsala, SWE, 753 09
Website
https://www.c-rad.com
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Asia Pacific region, and also has its presence in Europe, Middle East and Africa and the rest from Americas.

C-Rad AB Headlines

No Headlines